VCDraft

Add Company

Company

Sign in Sign up

VCDraft

© 2025 VC Draft. All rights reserved.

Biosplice Therapeutics

Provider of splicing modulation development solutions for multiple diseases

Valuation

$12B

Founded Year

2008

Location

San Diego(United States)

Industry

Portfolios

Valuation

Biosplice Therapeutics was last valued at $12B (Apr 2021)

Increased by 24,780% since inception

Jan 2010 - Apr 2021

Similar Companies

Portfolios

0

Biosplice Therapeutics: $12B valuation with 24,780% growth | VC Draft

Caris Life Sciences

$7.8B

Intarcia

$5B

Ori Biotech

$100M

BostonGene

$1B